Stability testing of new medical products or products in early stage clinical trial is one of the services offered by Chemika. Shelf life studies are complemented by method development and validation which allow our customers to register medicines or comm...
As a way of streamlining QA processes and keeping increasingly complex systems manageable, Chemika has implemented an electronic quality management system (eQMS).
Following vendor selection in 2022 impl...
In late April Chemika was the subject of an FDA audit of our operation. We have been registered as a facility with the FDA since November 2021, and this is the first time the FDA have travelled to audit us. Over the course of 3 days the auditor identified...
Chemika has updated its analytical equipment for analysis of metals. Our laboratory now boasts ICP-OES, ICP-MS and AAS all supplied by Perkin Elmer.
Perkin Elmer was chosen as supplier for these it...
A 61kW solar system has been installed on the roof of the Chemika Girraween laboratory with the aim of reducing power costs and reducing our greenhouse gas emissions. Our daytime operating hours means our highest power demand is on hot sunny days and this...
As a contribution to the Melbourne community, Chemika is now a sponsor of the St Kilda Cycling Club.
The cycling club is the biggest in Australia and also boasts having the highest proportion of fe...
Alan Doughty our Chief Chemist and Managing Director will be presenting a talk to our industry, this time in Melbourne at the PharmOut GMP Forum on 19-20 May, 2022 at Pullman Melbourne On The Park.
Mor...
On Tuesday 22nd March, RACI Pharmaceutical Science Group (NSW) and CAPSIG held a seminar "Preservatives and Preservative Efficacy: Pharmaceuticals and Cosmetics" with our Managing Director and Ch...
